Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study

Rok Seon Choung, Alberto Rubio-Tapia, Brian D. Lahr, Robert A. Kyle, Michael J. Camilleri, G. Richard Locke, Nicholas J. Talley, Joseph A Murray

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background & Aims: Celiac disease has been linked to irritable bowel syndrome (IBS)-like symptoms in outpatient clinics. Guidelines recommend that all patients with IBS-like symptoms undergo serologic testing for celiac disease, but there is controversy over whether celiac disease is more prevalent in populations with IBS-like symptoms. We aimed to determine whether positive results from serologic tests for celiac disease are associated with IBS and other functional gastrointestinal disorders (FGIDs) in a large U.S. white population. Methods: Validated, self-report bowel disease questionnaires (BDQs) were sent to randomly selected cohorts of Olmsted County, Minnesota residents. In separate protocols, serum samples were collected from more than 47,000 Olmsted County residents without a prior diagnosis of celiac disease; we performed serologic tests for celiac disease on stored serum samples from residents who completed the BDQ. Logistic regression was used to test for the association between serologic markers of celiac disease (positive vs negative) and individual FGIDs. Results: A total of 3202 subjects completed the BDQ and had serum available for testing. IBS was identified in 13.6% of these subjects (95% confidence interval [CI], 12.4%-14.8%), and any gastrointestinal symptom occurred in 55.2% (95% CI, 53.5%-56.9%). The prevalence of celiac disease on the basis of serologic markers was 1.0% (95% CI, 0.7%-1.4%). IBS was less prevalent in patients with celiac disease (3%) than patients without celiac disease (14%), although the difference was not statistically significant (odds ratio, 0.2; 95% CI, 0.03-1.5). Abdominal pain, constipation, weight loss, and dyspepsia were the most frequent symptom groups in subjects who were seropositive for celiac disease, but none of the gastrointestinal symptoms or disorders were significantly associated with celiac disease serology. Conclusions: Symptoms indicative of FGIDs and seropositive celiac disease are relatively common in a U.S. white community. Testing for celiac disease in patients with IBS in the community may not have a significantly increased yield over population-based screening in the United States.

Original languageEnglish (US)
Pages (from-to)1937-1943
Number of pages7
JournalClinical Gastroenterology and Hepatology
Volume13
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Gastrointestinal Diseases
Celiac Disease
Irritable Bowel Syndrome
Population
Confidence Intervals
Serologic Tests
Serum
Dyspepsia
Serology
Constipation
Ambulatory Care Facilities
Self Report
Abdominal Pain
Weight Loss

Keywords

  • Celiac Disease
  • Community Study
  • Gastrointestinal Symptoms

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease : A Population-based Study. / Choung, Rok Seon; Rubio-Tapia, Alberto; Lahr, Brian D.; Kyle, Robert A.; Camilleri, Michael J.; Locke, G. Richard; Talley, Nicholas J.; Murray, Joseph A.

In: Clinical Gastroenterology and Hepatology, Vol. 13, No. 11, 01.11.2015, p. 1937-1943.

Research output: Contribution to journalArticle

Choung, Rok Seon ; Rubio-Tapia, Alberto ; Lahr, Brian D. ; Kyle, Robert A. ; Camilleri, Michael J. ; Locke, G. Richard ; Talley, Nicholas J. ; Murray, Joseph A. / Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease : A Population-based Study. In: Clinical Gastroenterology and Hepatology. 2015 ; Vol. 13, No. 11. pp. 1937-1943.
@article{757d3fa5a675473a8fc43dd02e0d8fa4,
title = "Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study",
abstract = "Background & Aims: Celiac disease has been linked to irritable bowel syndrome (IBS)-like symptoms in outpatient clinics. Guidelines recommend that all patients with IBS-like symptoms undergo serologic testing for celiac disease, but there is controversy over whether celiac disease is more prevalent in populations with IBS-like symptoms. We aimed to determine whether positive results from serologic tests for celiac disease are associated with IBS and other functional gastrointestinal disorders (FGIDs) in a large U.S. white population. Methods: Validated, self-report bowel disease questionnaires (BDQs) were sent to randomly selected cohorts of Olmsted County, Minnesota residents. In separate protocols, serum samples were collected from more than 47,000 Olmsted County residents without a prior diagnosis of celiac disease; we performed serologic tests for celiac disease on stored serum samples from residents who completed the BDQ. Logistic regression was used to test for the association between serologic markers of celiac disease (positive vs negative) and individual FGIDs. Results: A total of 3202 subjects completed the BDQ and had serum available for testing. IBS was identified in 13.6{\%} of these subjects (95{\%} confidence interval [CI], 12.4{\%}-14.8{\%}), and any gastrointestinal symptom occurred in 55.2{\%} (95{\%} CI, 53.5{\%}-56.9{\%}). The prevalence of celiac disease on the basis of serologic markers was 1.0{\%} (95{\%} CI, 0.7{\%}-1.4{\%}). IBS was less prevalent in patients with celiac disease (3{\%}) than patients without celiac disease (14{\%}), although the difference was not statistically significant (odds ratio, 0.2; 95{\%} CI, 0.03-1.5). Abdominal pain, constipation, weight loss, and dyspepsia were the most frequent symptom groups in subjects who were seropositive for celiac disease, but none of the gastrointestinal symptoms or disorders were significantly associated with celiac disease serology. Conclusions: Symptoms indicative of FGIDs and seropositive celiac disease are relatively common in a U.S. white community. Testing for celiac disease in patients with IBS in the community may not have a significantly increased yield over population-based screening in the United States.",
keywords = "Celiac Disease, Community Study, Gastrointestinal Symptoms",
author = "Choung, {Rok Seon} and Alberto Rubio-Tapia and Lahr, {Brian D.} and Kyle, {Robert A.} and Camilleri, {Michael J.} and Locke, {G. Richard} and Talley, {Nicholas J.} and Murray, {Joseph A}",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.cgh.2015.05.014",
language = "English (US)",
volume = "13",
pages = "1937--1943",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease

T2 - A Population-based Study

AU - Choung, Rok Seon

AU - Rubio-Tapia, Alberto

AU - Lahr, Brian D.

AU - Kyle, Robert A.

AU - Camilleri, Michael J.

AU - Locke, G. Richard

AU - Talley, Nicholas J.

AU - Murray, Joseph A

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Background & Aims: Celiac disease has been linked to irritable bowel syndrome (IBS)-like symptoms in outpatient clinics. Guidelines recommend that all patients with IBS-like symptoms undergo serologic testing for celiac disease, but there is controversy over whether celiac disease is more prevalent in populations with IBS-like symptoms. We aimed to determine whether positive results from serologic tests for celiac disease are associated with IBS and other functional gastrointestinal disorders (FGIDs) in a large U.S. white population. Methods: Validated, self-report bowel disease questionnaires (BDQs) were sent to randomly selected cohorts of Olmsted County, Minnesota residents. In separate protocols, serum samples were collected from more than 47,000 Olmsted County residents without a prior diagnosis of celiac disease; we performed serologic tests for celiac disease on stored serum samples from residents who completed the BDQ. Logistic regression was used to test for the association between serologic markers of celiac disease (positive vs negative) and individual FGIDs. Results: A total of 3202 subjects completed the BDQ and had serum available for testing. IBS was identified in 13.6% of these subjects (95% confidence interval [CI], 12.4%-14.8%), and any gastrointestinal symptom occurred in 55.2% (95% CI, 53.5%-56.9%). The prevalence of celiac disease on the basis of serologic markers was 1.0% (95% CI, 0.7%-1.4%). IBS was less prevalent in patients with celiac disease (3%) than patients without celiac disease (14%), although the difference was not statistically significant (odds ratio, 0.2; 95% CI, 0.03-1.5). Abdominal pain, constipation, weight loss, and dyspepsia were the most frequent symptom groups in subjects who were seropositive for celiac disease, but none of the gastrointestinal symptoms or disorders were significantly associated with celiac disease serology. Conclusions: Symptoms indicative of FGIDs and seropositive celiac disease are relatively common in a U.S. white community. Testing for celiac disease in patients with IBS in the community may not have a significantly increased yield over population-based screening in the United States.

AB - Background & Aims: Celiac disease has been linked to irritable bowel syndrome (IBS)-like symptoms in outpatient clinics. Guidelines recommend that all patients with IBS-like symptoms undergo serologic testing for celiac disease, but there is controversy over whether celiac disease is more prevalent in populations with IBS-like symptoms. We aimed to determine whether positive results from serologic tests for celiac disease are associated with IBS and other functional gastrointestinal disorders (FGIDs) in a large U.S. white population. Methods: Validated, self-report bowel disease questionnaires (BDQs) were sent to randomly selected cohorts of Olmsted County, Minnesota residents. In separate protocols, serum samples were collected from more than 47,000 Olmsted County residents without a prior diagnosis of celiac disease; we performed serologic tests for celiac disease on stored serum samples from residents who completed the BDQ. Logistic regression was used to test for the association between serologic markers of celiac disease (positive vs negative) and individual FGIDs. Results: A total of 3202 subjects completed the BDQ and had serum available for testing. IBS was identified in 13.6% of these subjects (95% confidence interval [CI], 12.4%-14.8%), and any gastrointestinal symptom occurred in 55.2% (95% CI, 53.5%-56.9%). The prevalence of celiac disease on the basis of serologic markers was 1.0% (95% CI, 0.7%-1.4%). IBS was less prevalent in patients with celiac disease (3%) than patients without celiac disease (14%), although the difference was not statistically significant (odds ratio, 0.2; 95% CI, 0.03-1.5). Abdominal pain, constipation, weight loss, and dyspepsia were the most frequent symptom groups in subjects who were seropositive for celiac disease, but none of the gastrointestinal symptoms or disorders were significantly associated with celiac disease serology. Conclusions: Symptoms indicative of FGIDs and seropositive celiac disease are relatively common in a U.S. white community. Testing for celiac disease in patients with IBS in the community may not have a significantly increased yield over population-based screening in the United States.

KW - Celiac Disease

KW - Community Study

KW - Gastrointestinal Symptoms

UR - http://www.scopus.com/inward/record.url?scp=84944278742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944278742&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2015.05.014

DO - 10.1016/j.cgh.2015.05.014

M3 - Article

C2 - 25987301

AN - SCOPUS:84944278742

VL - 13

SP - 1937

EP - 1943

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 11

ER -